Human Anti-MAPT (clone IPN002) scFv-Fc Chimera

CAT#: VS-0325-FY121

The anti-MAPT scFv-Fc antibody targets Microtubule-Associated Protein Tau (MAPT), a protein implicated in neurodegenerative diseases such as Alzheimer's disease. It is designed to bind specifically to abnormal forms of MAPT, potentially aiding in the clearance of toxic aggregates. This antibody has potential applications in the treatment and diagnosis of tauopathies.

Gene Expression
Figure 1 IF staining of human cell line BJ Figure 2 IF staining of human cell line BJ Figure 3 Cerebral cortex Figure 4 Colon Figure 5 Kidney Figure 6 RNA cell line category: Group enriched (HDLM-2, SCLC-21H, T-47d)

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG1, scFv-Fc
  • Specificity
  • Human MAPT
  • Species Reactivity
  • Human
  • Clone
  • IPN002
  • Applications
  • ELISA, Flow Cytometry
  • Related Disease
  • Alzheimer's disease

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Target

  • Alternative Names
  • Microtubule Associated Protein Tau; G Protein Beta1/Gamma2 Subunit-Interacting Factor 1; Protein Phosphatase 1, Regulatory Subunit 103; Neurofibrillary Tangle Protein; Paired Helical Filament-Tau; PHF-Tau; MAPTL; MTBT1; TAU
  • Long Name
  • Microtubule Associated Protein Tau
  • Cellular Localization
  • Cell membrane; Cell projection; Cytoplasm; Cytoskeleton; Membrane; Microtubule; Secreted
  • Post Translation Modifications
  • Phosphorylation at serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases, and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1, MARK2, MARK3 or MARK4), causing detachment from microtubules, and their disassembly.
    Phosphorylation decreases with age.
    PHF-tau can be modified by three different forms of polyubiquitination. 'Lys-48'-linked polyubiquitination is the major form, 'Lys-6'-linked and 'Lys-11'-linked polyubiquitination also occur.
    O-glycosylated. O-GlcNAcylation content is around 8.2%.
    Glycation of PHF-tau, but not normal brain TAU/MAPT. Glycation is a non-enzymatic post-translational modification that involves a covalent linkage between a sugar and an amino group of a protein molecule forming ketoamine. Subsequent oxidation, fragmentation and/or cross-linking of ketoamine leads to the production of advanced glycation endproducts (AGES). Glycation may play a role in stabilizing PHF aggregation leading to tangle formation in AD.
  • Function
  • Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311).
    The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270).
    Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-0325-FY121. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Isotype Control

Secondary Antibody

See other products for "MAPT"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
BRD-0733MZ Chicken Anti-TAU Polyclonal IgY ICC, IF, IHC, WB Chicken antibody
CAT Product Name Application Type
PABX-174 Recombinant Mouse Anti-Tau5 Antibody WB, ELISA, Neut, FuncS IgG
PABX-174-S (P) Recombinant Mouse Anti-Tau5 Antibody scFv Fragment WB, ELISA, Neut, FuncS scFv
PABX-174-F (E) Recombinant Mouse Anti-Tau5 Antibody Fab Fragment WB, ELISA, Neut, FuncS Fab
CAT Product Name Application Type
NS-090CN Mouse Anti-MAPT Recombinant Antibody (NS-090CN) WB, ELISA, IHC, IP, SPR, FuncS Mouse IgG2b
CAT Product Name Application Type
VS-0424-XY182 AbPlus™ Anti-MAPT Magnetic Beads (VS-0424-XY182) IP, Protein Purification
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare